Eam Investors, LLC Sc Pharmaceuticals Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $860,090 - $1.13 Million	96,207 Added 56.82%	265,528 $2.71 Million
Q1 2023 Jul 12, 2023	SELL	$5.59 - $9.47 $36.4 Million - $61.6 Million	-6,505,811 Reduced 97.46%	169,321 $1.54 Million
Q1 2023 May 12, 2023	BUY	$5.59 - $9.47 $36.2 Million - $61.3 Million	6,472,304 Added 3191.03%	6,675,132 $60.5 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $815,368 - $1.53 Million	202,828 New	202,828 $1.45 Million

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $90.2M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.